Risk of chemotherapy-induced febrile neutropenia in intermediate-risk regimens: Clinical and economic outcomes of granulocyte colony-stimulating factor prophylaxisSaad Aslam, Gary H. Lyman, Elizabeth J. Bell et al.|Journal of Managed Care & Specialty Pharmacy|2023Cited by 8